World Journal of Surgical Oncology

Table 1 The clinicopathological relevance analysis of miR-1825 expression in GBM patients

From: Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathway

Characteristics	Cases	miR-1825		P value
Characteristics	Cases	High	Low	P value
Age (years)				0.761
≥ 60	25	9	16
< 60	30	12	18
Gender				0.399
Male	35	12	23
Female	20	10	12
WHO grade				0.022*
I + II	20	12	8
III + IV	35	10	25
Location				0.425
Supratentorial	30	14	16
Subtentorial	25	9	16

Statistical analyses were performed by the χ² test
*P < 0.05 was considered significant

Back to article page

ISSN: 1477-7819

Contact us

General enquiries: journalsubmissions@springernature.com